CMS Proposes Elimination of CME Exception to Sunshine Act Reporting

by Saul Ewing Arnstein & Lehr LLP


The Centers for Medicare and Medicaid Services (“CMS”) issued a proposed rule that includes a plan to eliminate the continuing medical education (“CME”) exclusion to the reporting requirements under the federal Physician Payment Sunshine Act (“Sunshine Act”). If the CME exclusion is eliminated, many payments made by applicable manufacturers to covered recipients may have to be reported to CMS through the Open Payments program on an annual basis.

The proposed changes to the Sunshine Act were included as part of a proposed rule to update the Medicare physician fee schedule for calendar year 2015.

The Sunshine Act was enacted as part of the Patient Protection and Affordable Care Act, and included a requirement for certain manufacturers of drugs, devices, biologics or medical supplies covered by Medicare, Medicaid or CHIP to report payments or transfers of value to physicians, dentists and teaching hospitals (called “covered recipients”) on an annual basis through the CMS Open Payments program. Saul Ewing has previously written alerts related to the Sunshine Act available here and here.

Under the current continuing education exclusion in the Sunshine Act regulations, applicable manufacturers need not report payments or transfers of value to a covered recipient for speaking at a continuing education event to CMS so long as the following conditions are met:

  • The event meets the certification requirements and standards for continuing education for one of the following organizations: the Accreditation Council for Continuing Medical Education; the American Academy of Family Physicians; the American Dental Association’s Continuing Education Recognition Program; the American Medical Association; or the American Osteopathic Association;
  • The applicable manufacturer must not pay the physician directly; and
  • The applicable manufacturer must not select the physician to speak or provide a third party with a distinct, identifiable set of individuals to be considered as speakers for the continuing education program.

In the preamble to the proposed rule, CMS stated that the current exclusion had the “unintended consequence” of CMS’ apparent endorsement or support of organizations sponsoring continuing education events.

In proposing to eliminate the continuing education exclusion, CMS stated that an existing Sunshine Act regulation exclusion may address many continuing education issues. Pursuant to 42 CFR §403.904(i)(1), transfers of value made where the applicable manufacturer is “unaware” of or “does not know” the identity of the physician during the reporting year, or by the end of the second quarter of the following reporting year, are excluded from reporting. CMS noted in the proposed rule preamble that, “When an applicable manufacturer or applicable [group purchasing organization] provides funding to a continuing education provider, but does not either select or pay the covered recipient speaker directly, or provide the continuing education provider with a distinct, identifiable set of covered recipients to be considered as speakers for the continuing education program, CMS will consider those payments to be excluded from reporting under §403.904(i)(1).”

In the preamble to the proposed rule, CMS stated that it considered two other approaches to addressing the current continuing education exclusion. First, it considered expanding the list of certifying organizations. However, CMS felt that this would imply CMS’ endorsement of certain continuing education providers over others. Second, CMS considered expanding the certifying organizations by stating accreditation or certification standards to permit a CME program to qualify. However, CMS stated this option would be difficult to monitor.

CMS is seeking comments to the proposed rule, which must be submitted on or before September 2, 2014.

Transparency in health care remains an important element of the policy debate. At least one industry group, the CME Coalition, has expressed concern with the proposed elimination of the CME exclusion. As manufacturers prepare for compliance with the Sunshine Act reporting requirements and covered recipients prepare for the public reaction that may result from the initial disclosures that are made, the proposed modification published by CMS for CME expenditure disclosure may spur additional debate requiring industry support for continuing medical education programming.

DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© Saul Ewing Arnstein & Lehr LLP | Attorney Advertising

Written by:

Saul Ewing Arnstein & Lehr LLP

Saul Ewing Arnstein & Lehr LLP on:

Readers' Choice 2017
Reporters on Deadline

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
Sign up using*

Already signed up? Log in here

*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
Custom Email Digest
Privacy Policy (Updated: October 8, 2015):

JD Supra provides users with access to its legal industry publishing services (the "Service") through its website (the "Website") as well as through other sources. Our policies with regard to data collection and use of personal information of users of the Service, regardless of the manner in which users access the Service, and visitors to the Website are set forth in this statement ("Policy"). By using the Service, you signify your acceptance of this Policy.

Information Collection and Use by JD Supra

JD Supra collects users' names, companies, titles, e-mail address and industry. JD Supra also tracks the pages that users visit, logs IP addresses and aggregates non-personally identifiable user data and browser type. This data is gathered using cookies and other technologies.

The information and data collected is used to authenticate users and to send notifications relating to the Service, including email alerts to which users have subscribed; to manage the Service and Website, to improve the Service and to customize the user's experience. This information is also provided to the authors of the content to give them insight into their readership and help them to improve their content, so that it is most useful for our users.

JD Supra does not sell, rent or otherwise provide your details to third parties, other than to the authors of the content on JD Supra.

If you prefer not to enable cookies, you may change your browser settings to disable cookies; however, please note that rejecting cookies while visiting the Website may result in certain parts of the Website not operating correctly or as efficiently as if cookies were allowed.

Email Choice/Opt-out

Users who opt in to receive emails may choose to no longer receive e-mail updates and newsletters by selecting the "opt-out of future email" option in the email they receive from JD Supra or in their JD Supra account management screen.


JD Supra takes reasonable precautions to insure that user information is kept private. We restrict access to user information to those individuals who reasonably need access to perform their job functions, such as our third party email service, customer service personnel and technical staff. However, please note that no method of transmitting or storing data is completely secure and we cannot guarantee the security of user information. Unauthorized entry or use, hardware or software failure, and other factors may compromise the security of user information at any time.

If you have reason to believe that your interaction with us is no longer secure, you must immediately notify us of the problem by contacting us at In the unlikely event that we believe that the security of your user information in our possession or control may have been compromised, we may seek to notify you of that development and, if so, will endeavor to do so as promptly as practicable under the circumstances.

Sharing and Disclosure of Information JD Supra Collects

Except as otherwise described in this privacy statement, JD Supra will not disclose personal information to any third party unless we believe that disclosure is necessary to: (1) comply with applicable laws; (2) respond to governmental inquiries or requests; (3) comply with valid legal process; (4) protect the rights, privacy, safety or property of JD Supra, users of the Service, Website visitors or the public; (5) permit us to pursue available remedies or limit the damages that we may sustain; and (6) enforce our Terms & Conditions of Use.

In the event there is a change in the corporate structure of JD Supra such as, but not limited to, merger, consolidation, sale, liquidation or transfer of substantial assets, JD Supra may, in its sole discretion, transfer, sell or assign information collected on and through the Service to one or more affiliated or unaffiliated third parties.

Links to Other Websites

This Website and the Service may contain links to other websites. The operator of such other websites may collect information about you, including through cookies or other technologies. If you are using the Service through the Website and link to another site, you will leave the Website and this Policy will not apply to your use of and activity on those other sites. We encourage you to read the legal notices posted on those sites, including their privacy policies. We shall have no responsibility or liability for your visitation to, and the data collection and use practices of, such other sites. This Policy applies solely to the information collected in connection with your use of this Website and does not apply to any practices conducted offline or in connection with any other websites.

Changes in Our Privacy Policy

We reserve the right to change this Policy at any time. Please refer to the date at the top of this page to determine when this Policy was last revised. Any changes to our privacy policy will become effective upon posting of the revised policy on the Website. By continuing to use the Service or Website following such changes, you will be deemed to have agreed to such changes. If you do not agree with the terms of this Policy, as it may be amended from time to time, in whole or part, please do not continue using the Service or the Website.

Contacting JD Supra

If you have any questions about this privacy statement, the practices of this site, your dealings with this Web site, or if you would like to change any of the information you have provided to us, please contact us at:

- hide
*With LinkedIn, you don't need to create a separate login to manage your free JD Supra account, and we can make suggestions based on your needs and interests. We will not post anything on LinkedIn in your name. Or, sign up using your email address.